CReATe Fertility Center, University of Toronto, 790 Bay Street, Suite 1100, Toronto, ON, Canada M5G 1N8 Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON, Canada.
CReATe Fertility Center, University of Toronto, 790 Bay Street, Suite 1100, Toronto, ON, Canada M5G 1N8.
Hum Reprod. 2015 Feb;30(2):345-52. doi: 10.1093/humrep/deu333. Epub 2014 Dec 17.
What are the medical, psychosocial and legal aspects of gestational surrogacy (GS), including pregnancy outcomes and complications, in a large series?
Meticulous multidisciplinary teamwork, involving medical, legal and psychosocial input for both the intended parent(s) (IP) and the gestational carrier (GC), is critical to achieve a successful GS program.
Small case series have described pregnancy rates of 17-50% for GS. There are no large case series and the medical, legal and psychological aspects of GS have not been addressed in most of these studies. To our knowledge, this is the largest reported GS case series.
STUDY DESIGN, SIZE AND DURATION: A retrospective cohort study was performed. Data were collected from 333 consecutive GC cycles between 1998 and 2012.
PARTICIPANTS/MATERIALS, SETTING, METHODS: There were 178 pregnancies achieved out of 333 stimulation cycles, including fresh and frozen transfers. The indications for a GC were divided into two groups. Those who have 'failed to carry', included women with recurrent implantation failure (RIF), recurrent pregnancy loss (RPL) and previous poor pregnancy outcome (n = 96; 132 cycles, pregnancy rate 50.0%). The second group consisted of those who 'cannot carry' including those with severe Asherman's syndrome, uterine malformations/uterine agenesis and maternal medical diseases (n = 108, 139 cycles, pregnancy rate 54.0%). A third group, of same-sex male couples and single men, were analyzed separately (n = 52, 62 cycles, pregnancy rate 59.7%). In 49.2% of cycles, autologous oocytes were used and 50.8% of cycles involved donor oocytes.
The 'failed to carry' group consisted of 96 patients who underwent 132 cycles at a mean age of 40.3 years. There were 66 pregnancies (50.0%) with 17 miscarriages (25.8%) and 46 confirmed births (34.8%). The 'cannot carry pregnancy' group consisted of 108 patients who underwent 139 cycles at a mean age of 35.9 years. There were 75 pregnancies (54.0%) with 15 miscarriages (20.0%) and 56 confirmed births (40.3%). The pregnancy, miscarriage and live birth rates between the two groups were not significantly different (P = 0.54; 0.43; 0.38, respectively). Of the 178 pregnancies, 142 pregnancies were ongoing (surpassed 20 weeks) or had ended with a live birth and the other 36 pregnancies resulted in miscarriage (25.4%). Maternal (GS) complication rates were low, occurring in only 9.8% of pregnancies. Fetal anomalies occurred in only 1.8% of the babies born.
LIMITATIONS, REASONS FOR CAUTION: Although it is a large series, the data are retrospective and conclusions must be drawn accordingly while considering bias, confounding and power. Due to the retrospective nature of this study, follow-up data on 6.3% of birth outcomes were incomplete. In addition, long-term follow-up data on GCs and IPs were not available to us at the time of publication.
To our knowledge, this is the largest GS series published. We have included many details regarding not only the medical protocol but also the counseling and legal considerations, which are an inseparable part of the process. Data from this study can be included in discussions with future intended parents and gestational carriers regarding success rates and complications of GS.
在一个大型系列中,代孕(GS)的医学、心理社会和法律方面包括妊娠结局和并发症是什么?
精心的多学科团队合作,包括为预期父母(IP)和代孕母亲(GC)提供医疗、法律和心理社会方面的投入,对于实现成功的 GS 计划至关重要。
小案例系列已经描述了 GS 的妊娠率为 17-50%。大多数这些研究中没有大型案例系列,也没有涉及 GS 的医学、法律和心理方面。据我们所知,这是报告的最大 GS 案例系列。
研究设计、大小和持续时间:进行了回顾性队列研究。数据是从 1998 年至 2012 年期间的 333 个连续 GC 周期中收集的。
参与者/材料、设置、方法:在 333 个刺激周期中实现了 178 次妊娠,包括新鲜和冷冻转移。代孕的适应症分为两组。那些“无法携带”的人包括反复着床失败(RIF)、反复妊娠丢失(RPL)和先前不良妊娠结局的患者(n = 96;132 个周期,妊娠率 50.0%)。第二组包括那些“不能携带”的人,包括严重的 Asherman 综合征、子宫畸形/子宫发育不全和母体疾病患者(n = 108,139 个周期,妊娠率 54.0%)。第三组,包括同性男性伴侣和单身男性,分别进行了分析(n = 52,62 个周期,妊娠率 59.7%)。在 49.2%的周期中使用了自体卵,50.8%的周期涉及供体卵。
“无法携带”组包括 96 名患者,他们进行了 132 个周期,平均年龄为 40.3 岁。有 66 次妊娠(50.0%),17 次流产(25.8%)和 46 次确认分娩(34.8%)。“无法携带妊娠”组包括 108 名患者,他们进行了 139 个周期,平均年龄为 35.9 岁。有 75 次妊娠(54.0%),15 次流产(20.0%)和 56 次确认分娩(40.3%)。两组之间的妊娠、流产和活产率没有显著差异(P = 0.54;0.43;0.38)。在 178 次妊娠中,142 次妊娠仍在继续(超过 20 周)或已结束并分娩,36 次妊娠导致流产(25.4%)。母体(GS)并发症发生率较低,仅发生在 9.8%的妊娠中。出生婴儿中仅发生 1.8%的胎儿异常。
局限性、谨慎的原因:尽管这是一个大型系列,但数据是回顾性的,因此在考虑偏倚、混杂和功效时,必须得出相应的结论。由于这项研究是回顾性的,只有 6.3%的出生结局的随访数据不完整。此外,我们在发表时无法获得有关 GC 和 IP 的长期随访数据。
据我们所知,这是发表的最大 GS 系列。我们不仅包括了许多关于医疗方案的详细信息,还包括了咨询和法律考虑,这是该过程不可分割的一部分。这项研究的数据可以包括在与未来的预期父母和代孕母亲讨论代孕的成功率和并发症中。